Alto Neuroscience (ANRO) Other Working Capital Changes (2023 - 2026)

Alto Neuroscience has reported Other Working Capital Changes for 4 years, with the latest figure at $4.1 million in Q1 2026.

• Quarterly Other Working Capital Changes rose 144.09% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 524.87% YoY) and the FY2025 annual result came in at -$101000.0, down 121.81% from the prior year.
• Other Working Capital Changes grew to $4.1 million in Q1 2026 per ANRO's latest filing, from -$656000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $4.1 million in Q1 2026 and troughed at -$744000.0 in Q3 2024.
• A 4-year average of $323153.8 and a median of -$387000.0 in 2023 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 283.84% in 2024, down 1007.32% in 2024.
• Over 4 years, Other Working Capital Changes stood at -$450000.0 in 2023, then changed by 0.0% to -$450000.0 in 2024, then slumped by 45.78% to -$656000.0 in 2025, then jumped by 729.57% to $4.1 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $4.1 million, -$656000.0, and -$628000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.